Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MiCLASP Post Market Clinical Follow-Up (PMCF) Study

NCT: NCT04430075 · ACTIVE_NOT_RECRUITING

NCT IDNCT04430075
StatusACTIVE_NOT_RECRUITING
Start Date2019-08-23
Completion2031-03-31
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System and the Edwards PASCAL Precision Transcatheter Valve Repair System in transcatheter mitral valve repair.

Frequently Asked Questions

What is MiCLASP Post Market Clinical Follow-Up (PMCF) Study?

MiCLASP Post Market Clinical Follow-Up (PMCF) Study is a clinical trial registered under NCT04430075. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04430075?

The current status of NCT04430075 (MiCLASP Post Market Clinical Follow-Up (PMCF) Study) is: ACTIVE_NOT_RECRUITING.

When did MiCLASP Post Market Clinical Follow-Up (PMCF) Study start?

MiCLASP Post Market Clinical Follow-Up (PMCF) Study started on 2019-08-23.

Related Devices

PMA P220003Mitral valve repair devicesEdwards Lifesciences, LLC PMA P250019Prosthesis, mitral valve, percutaneously deliveredEdwards Lifesciences, LLC K152980Flo Trac sensor, Volume View sensorEdwards Lifesciences, LLC K153069Edwards Balloon CatheterEdwards Lifesciences K160084Swan Ganz CathetersEdwards Lifesciences, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑